Last updated: 10 August 2022 at 5:19pm EST

Dr. Grant Blouse M.Sc., Ph.D. Net Worth




The estimated Net Worth of Grant E. Blouse is at least $4.8 Tysiąc dollars as of 9 August 2022. Dr Blouse owns over 3,250 units of Catalyst Biosciences Inc stock worth over $4,803 and over the last 3 years he sold CBIO stock worth over $0.

Dr D CBIO stock SEC Form 4 insiders trading

Dr has made over 3 trades of the Catalyst Biosciences Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 3,250 units of CBIO stock worth $1,528 on 9 August 2022.

The largest trade he's ever made was buying 3,250 units of Catalyst Biosciences Inc stock on 9 August 2022 worth over $1,528. On average, Dr trades about 1,916 units every 91 days since 2021. As of 9 August 2022 he still owns at least 9,417 units of Catalyst Biosciences Inc stock.

You can see the complete history of Dr Blouse stock trades at the bottom of the page.





Dr. Grant Blouse M.Sc., Ph.D. biography

Dr. Grant Blouse M.Sc., Ph.D. is the Chief Scientific Officer at Catalyst Biosciences Inc.



What's Dr D's mailing address?

Grant's mailing address filed with the SEC is C/O CATALYST BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 710, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Catalyst Biosciences Inc

Over the last 9 years, insiders at Catalyst Biosciences Inc have traded over $2,614,728 worth of Catalyst Biosciences Inc stock and bought 81,771 units worth $199,380 . The most active insiders traders include Jeff Himawan, James E Deerfield Mgmt L.P.... oraz Augustine Lawlor. On average, Catalyst Biosciences Inc executives and independent directors trade stock every 62 days with the average trade being worth of $3,315. The most recent stock trade was executed by Nassim Usman on 9 August 2022, trading 3,250 units of CBIO stock currently worth $1,528.



What does Catalyst Biosciences Inc do?

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.



What does Catalyst Biosciences Inc's logo look like?

Catalyst Biosciences Inc logo

Complete history of Dr Blouse stock trades at Catalyst Biosciences Inc

Data
#
Firma
Osoba
Trans.
Transakcja
Ilość akcji Cena za akcję Łączna cena Ilość akcji po Źródło
9 Aug 2022 Grant E. Blouse
Chief Scientific Officer
Kupować 3,250 $0.47 $1,528
9 Aug 2022
9,417
9 Feb 2022 Grant E. Blouse
Chief Scientific Officer
Kupować 3,250 $0.46 $1,495
9 Feb 2022
6,167
9 Aug 2021 Grant E. Blouse
Chief Scientific Officer
Kupować 1,163 $3.62 $4,210
9 Aug 2021
2,917


Catalyst Biosciences Inc executives and stock owners

Catalyst Biosciences Inc executives and other stock owners filed with the SEC include: